Ken Griffin Enzo Biochem Inc Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Enzo Biochem Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 34,000 shares of ENZ stock, worth $39,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,000Holding current value
$39,440% of portfolio
0.0%Shares
24 transactions
Others Institutions Holding ENZ
# of Institutions
46Shares Held
15.3MCall Options Held
34KPut Options Held
0-
Harbert Fund Advisors, Inc. Birmingham, AL5.18MShares$6 Million4.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.53MShares$2.93 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$2.18 Million0.0% of portfolio
-
Potomac Capital Management, Inc.1.48MShares$1.72 Million3.63% of portfolio
-
Viex Capital Advisors, LLC Sunny Isles Beach, FL1.33MShares$1.55 Million9.62% of portfolio
About ENZO BIOCHEM INC
- Ticker ENZ
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 48,720,500
- Market Cap $56.5M
- Description
- Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...